Last updated on July 2019

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder


Brief description of study

A study to evaluate Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 with or without BCG in BCG-Unresponsive non-muscle invasive Bladder Cancer

Clinical Study Identifier: NCT03519256

Find a site near you

Start Over

Local Institution

Phoenix, AZ United States
  Connect »

Local Institution

Riverside, CA United States
  Connect »

Local Institution

San Francisco, CA United States
  Connect »

The University Of Chicago

Chicago, IL United States
  Connect »

Local Institution

Shreveport, LA United States
  Connect »

Local Institution

Baltimore, MD United States
  Connect »

Local Institution

Minneapolis, MN United States
  Connect »

Local Institution

New York, NY United States
  Connect »

Local Institution

Springfield, OR United States
  Connect »

Local Institution

Hershey, PA United States
  Connect »

Local Institution

Nashville, TN United States
  Connect »

Local Institution

Lubbock, TX United States
  Connect »

Local Institution

Virginia Beach, VA United States
  Connect »

Local Institution

Porto Alegre, Brazil
  Connect »

Local Institution

Itacorubi, Florianopolis, Brazil
  Connect »

Local Institution

St. John's, NL Canada
  Connect »

Local Institution

Sherbrooke, QC Canada
  Connect »

Local Institution

Amsterdam, Netherlands
  Connect »

Local Institution

Nijmegen, Netherlands
  Connect »

Local Institution

Utrecht, Netherlands
  Connect »

Local Institution

Omsk, Russian Federation
  Connect »

Local Institution

Saint-Petersburg, Russian Federation
  Connect »

Local Institution

Chelmsford, United Kingdom
  Connect »

Local Institution

Lancaster, United Kingdom
  Connect »

Local Institution

London, United Kingdom
  Connect »

Local Institution

Southampton, United Kingdom
  Connect »

Erlanger Health System

Chattanooga, TN United States
  Connect »

Local Institution

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Local Institution

LILLE Cedex, France
  Connect »

Local Institution

Strasbourg Cedex, France
  Connect »

Local Institution

Hong Kong, Hong Kong
  Connect »

Emory University

Atlanta, GA United States
  Connect »

Local Institution

Westwood, KS United States
  Connect »

Carolina Urologic Research Center

Myrtle Beach, SC United States
  Connect »

Wichita Urology Group

Wichita, KS United States
  Connect »

Urology San Antonio Research, Pa

San Antonio, TX United States
  Connect »

Moffitt Cancer Center

Tampa, FL United States
  Connect »

Deleware Valley Urology, LLC

Voorhees, NJ United States
  Connect »

James Cancer Hospital

Columbus, OH United States
  Connect »

MidLantic Urology

Bala-Cynwyd, PA United States
  Connect »

MD Anderson Cancer Center

Houston, TX United States
  Connect »

Hospital Britanico De Buenos Aires

Ciudad Autonoma de Buenos Aires, Argentina
  Connect »

University Of Michigan

Ann Arbor, MI United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.